M. T. Gomez

The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamic-pituitary-adrenal axis through a centrally-mediated corticotropin-releasing hormone-dependent mechanism.

E. O. Johnson, G. Chrousos, P. Gold, 1989, Endocrinology.

Interactions between tumor necrosis factor-alpha, hypothalamic corticotropin-releasing hormone, and adrenocorticotropin secretion in the rat.

E. O. Johnson, G. Chrousos, P. Gold, 1990, Endocrinology.

Cushing syndrome due to primary pigmented nodular adrenocortical disease: findings at CT and MR imaging.

W. Travis, J. Norton, J. Doppman, 1989, Radiology.

β-Endorphin responses to different serotonin agonists: involvement of corticotropin-releasing hormone, vasopressin and direct pituitary action

D. Murphy, G. Chrousos, P. Gold, 1990, Brain Research.

Suppressed spontaneous and stimulated growth hormone secretion in patients with Cushing's disease before and after surgical cure.

G. Chrousos, G. Mastorakos, M. T. Gomez, 1994, The Journal of clinical endocrinology and metabolism.

Cushing's syndrome in children and adolescents. Presentation, diagnosis, and therapy.

J. Doppman, G. Chrousos, E. Oldfield, 1994, The New England journal of medicine.

The pituitary corticotroph is not the rate limiting step in the postoperative recovery of the hypothalamic-pituitary-adrenal axis in patients with Cushing syndrome.

G. Chrousos, G. Mastorakos, M. T. Gomez, 1993, The Journal of clinical endocrinology and metabolism.

Urinary free cortisol values in normal children and adolescents.

G. Chrousos, N. Vamvakopoulos, M. T. Gomez, 1991, The Journal of pediatrics.